Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

enGene Therapeutics Inc.

Biological Products, (No Diagnostic Substances) · Saint-Laurent

  1. PrincipalsAnthony Tzeyew CheungChief Scientific OfficerD. Ryan DawsChief Financial OfficerHussein SweitiChief Medical Officerand 6 more
  2. CompanyenGene Therapeutics Inc.Saint-Laurent
  3. Phone line+1 (514) 332-4888General business
Request a quote

enGene Therapeutics Inc. is an SEC-registered Nasdaq-listed company (ticker ENGN) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 9

Chief executive

Finance

D. Ryan DawsChief Financial Officer

Technology & engineering

Joan ConnollyChief Technology Officer

Legal

Lee GiguereChief Legal Ofc. and Corp Secy
Everyone else on file (5)
Anthony Tzeyew CheungChief Scientific Officer
Hussein SweitiChief Medical Officer
Jill BuckChief Development Officer
Matthew Ross BoydChief Regulatory Officer
Alexander Julian NicholsChief Strategy & Ops. Ofc

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Anthony Tzeyew Cheung — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. D. Ryan Daws — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Jill Buck — Chief Development Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Hussein Sweiti — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers